Skip Navigation

Yepes Laboratory People

Manuel Yepes, MD
Manuel Yepes was trained and board certified as a Neurologist and Vascular Neurologist in Georgetown University in Washington, D.C., where he was elected to the Alpha Omega Alpha Honor Medical Society and became the director of the Stroke Center & Ultrasound Laboratory. In 2004 he moved to Emory University where he is Professor of Neurology (with tenure) and member of the Center for Neurodegenerative Disease. He is also the Director of the Atlanta VAMC Stroke Team and the O. Wayne Rollins Endowed Chair in Stroke and Imaging Research at Yerkes National Primate Research Center. As a clinician he is actively involved in the care of stroke patients in Emory University Hospital and the VAMC. As a scientist he directs a laboratory of cerebrovascular neuroscience in the Center for Neurodegenerative Disease in Emory University that studies the molecular mechanisms of neuronal death and survival in the ischemic brain. He also leads a research program in stroke and neuroimaging at Yerkes National Primate Research Center. Dr. Yepes is fellow member of the American Society for Clinical Investigation, American Neurological Association, American Academy of Neurology, Society for Neuroscience, and American Stroke Association..

Click here for publications list.

Dr Yepes

Fang Wu, PhD
Fang Wu received her PhD degree from University of Science and Technology (USTC) in China in 2004. She joined the Department of Pharmacology at Emory University as post-doctoral fellow to study signaling pathways associated with neurodegenerative diseases. In 2010 she joined the Yepes laboratory to study the molecular mechanisms underlying the neuroprotective effect of tissue-type plasminogen activator in the ischemic brain.


Enrique Torre, PhD
Enrique Torre received a PhD degree in chemistry from the Instituto de Investigación Médica MM Ferreira/Universidad Nacional de Córdoba, in Argentina in 1986.  His research focuses on the role of tissue-type plasminogen activator in the development of synaptic plasticity under physiological and pathological conditions such as cerebral ischemia. 


Lihong Cheng, MD
Dr. Cheng is a physician from Hunan medical school in China with extensive expertise in small animal surgery and molecular biology.  Dr. Chen studies the effects of urokinase-type plasmnogen activator in the ischemic brain.


Paola Merino, PhD

Dr. Merino received a Ph.D. degree in molecular biosciences from the University Andres Bello, in Santiago de Chile (Chile). Then she worked in the Foundation Science and Life in Chile where she studied the synthesis of histones and epigenetic markers. In 2016 she joined the Yepes laboratory as postdoctoral fellow to study the effect of urokinase-type plasminogen activator (uPA) in neurepair.

Paola Merino

Ariel Diaz, PhD
Ariel Diaz received a PhD degree in Biochemistry from Universidad de Chile. His studies focus on cell signaling and cerebral ischemia. He joined the Yepes laboratory in 2016 where he studies the role of astrocytic urokinase-type plasminogen activator receptor (uPAR) during brain damage.

Ariel Diaz

Valeria Jeanneret, MD
Valerie Jeanneret is a physician graduated from Universidad de los Andes, in Bogotá, Colombia. Her passion for clinical neurology and her interest in studying the molecular aspects underlying brain function and disease brought her to the Yepes laboratory to study the modulatory effects of tPA on the post-synaptic compartment and the role of tPA as a synaptic protector.

Valerie Jeanneret

Yepes Laboratory